The health ministry is weighing mixing and matching different COVID-19 vaccines to help ease supply concerns and accelerate the country’s inoculation program, the minister in charge of vaccinations said Sunday.
Japan has mostly used COVID-19 vaccines developed by Pfizer Inc. and Moderna Inc. for its inoculation program. AstraZeneca PLC’s vaccine, manufactured in Japan under a license, was approved in July for use in people age 40 or older.
“We can expect an acceleration in vaccinations if we gain approval” for the mixed-dose approach from the Ministry of Health, Labor and Welfare, Taro Kono said on a television program.
As of Thursday, 43.5% of the country’s population had received two doses.
As for the administration of a third vaccine shot, which is already under consideration in response to reduced efficacy and breakthrough infection cases among fully vaccinated people, Kono said that, once authorized, this can be started for health care workers in October at the earliest and for people age 65 or older in January or February.
“We have already secured the necessary quantities” for a booster shot rollout, Kono said.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.
SUBSCRIBE NOW
